Skip to main content
. 2017 Mar 21;3(1):11–20. doi: 10.1016/j.ijwd.2017.01.004

Table 3.

Proposed post-treatment regimen

Immediate Posttreatment Topical Tyrosinase inhibitor immediately posttherapy High potency topical corticosteroid two times daily for 3 days postprocedure
Two Weeks Posttreatment Control of risk factors (sun protection, discontinue hormone treatments) with:
  • -

    Topical anti-Tyrosinase therapy daily

  • -

    Other inhibitors of the melanin synthetic pathway (e.g., PAR-2 inhibitor)
Long-term Posttreatment Control of risk factors (sun protection, discontinue hormone treatments) with:
  • -

    Topical anti-Tyrosinase therapy daily

  • -

    Other inhibitors of the melanin synthetic pathway (e.g., PAR-2 inhibitor)

  • -

    Resume topical exfoliant daily, if tolerated

  • -

    Resume triple combination topical cream, if tolerated

PAR-2, protease-activated receptor-2.